Jim Cramer on Hims & Hers: “You Gotta Generate Some Discipline Here”

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 14 stocks Jim Cramer recently shared insights on. Discussing the importance of discipline over conviction, Cramer commented:

“No matter how much you love these speculative winners, you don’t have a gain until you actually ring the register. At the end of last week, for example, Hims & Hers Health, the online healthcare company, was trading at $64. But then yesterday, the stock fell 22 bucks for an almost 35% decline… What I care about is that this stock… [has] almost tripled in two months. If you owned Hims & Hers up almost 200% and you hadn’t sold any at that point, you were being a knucklehead.

Why? Because this is one of the most heavily shorted stocks in the market. 35% of the shares sold short. A lot of people have been betting against it. The haters are plentiful. In that situation, the stock can erupt on any good news. And there was a lot of good news when HIMS was making money with the Wegovy deal.

But a lot of those gains came on the backs of the short sellers who were forced to cover or buy back the shares they sold short because they couldn’t take the pain. That’s why when a stock goes up that fast and there’s a big short position, you gotta generate some discipline here.”

Jim Cramer on Hims & Hers: "You Gotta Generate Some Discipline Here"

A nurse in a telehealth platform talking with a patient on video call for consultation.

Hims & Hers Health (NYSE:HIMS) operates a telehealth platform that delivers prescription and non-prescription health and wellness products. The company’s products include medication, skin care, sexual health, hair care, and wellness items, supported by ongoing care from licensed healthcare professionals.

While we acknowledge the potential of HIMS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.